The Nrf2 signaling pathway has been reported to play an antioxidant role in nonalcoholic steatohepatitis [24], liver fibrosis [25], and liver ischemia/reperfusion [26], which may offer a novel potential strategy for the prevention and treatment of liver diseases [27]. Here, NFE2L2 is linked to Hepatic fibrosis.